Guidance in topic selection
Showing 1 to 5 of 5
| Title | Technology type | Decision | Decision date |
|---|---|---|---|
| Basal insulin icodec–semaglutide for treating type 2 diabetes inadequately controlled with daily basal insulin TSID 11940 | Medicine | Not selected | |
| PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes, (MT740) | Diagnostic | Not selected | |
| Semaglutide for treating type 2 diabetes and associated peripheral arterial disease TS ID 11791 | Medicine | Not selected | |
| Dulaglutide for treating type 2 diabetes in children and young people TS ID 10660 | Medicine | Not selected | |
| d-NAV for optimization of personal insulin management in adults with type 2 diabetes (MT696) | Device | Not selected |